| Serial Number | 99465741 |
| Word Mark | BYRULA |
| Filing Date | Tuesday, October 28, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, April 29, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Radiotherapy apparatus and instruments; implantable radioactive devices being sources of radiation for cancer therapy; instruments and apparatus for immunotherapy and immuno-diagnostics; medical test equipment, namely, positron emission tomography (PET) cameras, detection probes, well-counters and devices that visualize or quantify emissions from diagnostic and therapeutic radiopharmaceuticals; blood analysers being apparatus for medical diagnosis; diagnostic devices for medical purposes, namely, medical imaging and detection devices; electrodes for medical purposes; injection syringes; instrument cases fitted for medical instruments for use by doctors and surgeons; fitted cases for medical instruments; masks for medical staff; pumps for medical purposes, namely, vacuum pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers for protection against ionising radiation for medical use; insulated containers for temperature sensitive products for medical use, namely, insulated containers designed for transporting and holding radiopharmaceuticals; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for dosimetry in the field of radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; apparatus for administering pharmaceuticals; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments for the intravenous delivery of pharmaceuticals; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication; Medical apparatus kit comprising of a pre-filled multi-dose vial with syringe shield or pre-filled syringe with IV ready cap and syringe shield for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products; medical apparatus for use by healthcare providers; medical instruments for use by healthcare providers; medical apparatus for diagnostic radiopharmaceutical use; medical instruments for diagnostic radiopharmaceutical use; medical apparatus for diagnostic contrast agent use; medical instruments for diagnostic contrast agent use; medical apparatus for diagnostic tumor-seeking tracer use; medical instruments for diagnostic tumor-seeking tracer use; medical apparatus for diagnostic molecular-imaging probe use; medical instruments for diagnostic molecular-imaging probe use; molecular-imaging probes for diagnostic purposes; structural parts and fittings for the aforesaid goods |
| Goods and Services | Provision of medical and health care services; provision of medical and health care services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical counselling services in the field of treatment, prophylaxis or prevention of medical conditions; health care services, namely, psychedelic therapy; psychotherapy; medical treatment and psychotherapy incorporating virtual reality; providing medical advice relating to pharmaceuticals; alternative medicine services; providing medical information in the field of cancer diagnosis; information, support in the nature of consultancy, and assistance in the nature of advisory services in relation to the aforementioned services |
| Goods and Services | Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for use in the treatment of cancer; pharmaceutical preparations and substances being reagents for medical diagnosis; pharmaceutical preparations and substances for therapy and treatment of cancer; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals for use in the diagnosis and treatment of cancers; radioprotectors being pharmaceutical preparations for use in the treatment of cancer; radiopharmaceuticals for use in theranostics; radiopharmaceutical preparations for use in the treatment of cancer; radiopharmaceutical medical diagnostic preparations and therapeutic preparations for medical purposes for use in the treatment of cancer; radiopharmaceuticals for medical and clinical use for use in the treatment of cancer; radiopharmaceutical preparations for nuclear medicine for use in the treatment of cancer; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations for use in the treatment of cancer; chemical substances and preparations being radioactive substances for medical purposes for use in the treatment of cancer; radioisotopes for medical purposes for use in the treatment of cancer; medical diagnostic radioisotopes and radiochemicals and therapeutic radioisotopes and radiochemicals for medical purposes for use in the treatment of cancer; radiopharmaceutical preparations and substances for endo-radionuclide therapy and brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, namely, medical imaging and for use as therapy for use in the treatment of cancer; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics being pharmaceutical preparations for use in the field of oncology; theranostics being pharmaceutical preparations for use in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule for use in the treatment of cancer; preparations for targeted radionuclide therapy for use in the treatment of cancer; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres being pharmaceutical preparations used for therapeutic medical purposes for use in the treatment of cancer; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for medical diagnostic applications; chemicals for pharmaceutical use for use in the treatment of cancer; chemicals being radiopharmaceuticals for medical diagnostic uses; pharmaceutical drugs for use in the treatment of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 28, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 28, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 28, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Clarity Pharmaceuticals Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Eveleigh, NSW 2015 AU |
| Event Date | Event Description |
| Tuesday, October 28, 2025 | NEW APPLICATION ENTERED |
| Tuesday, November 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 11, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 12, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 16, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, March 16, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 16, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 29, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 29, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 29, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |